Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Improving these processes involves fine-tuning various parameters, including cell line development, media formulation, and bioreactor settings. A key goal is to amplify antibody yield while lowering production expense